Mutations in the U4 snRNA gene RNU4-2 cause one of the most prevalent monogenic neurodevelopmental disorders
Nature Medicine · 2024-08 · 30 (8) · 2165-2169
DOI: 10.1038/s41591-024-03085-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nature Medicine, online erschienen am 31.05.2024. Verfasst von Daniel Greene und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Cambridge, Cambridge, UK. Hauptthemen laut MEDLINE: RNA, Small Nuclear, Neurodevelopmental Disorders, Intellectual Disability, Mutation. Die Arbeit wurde bisher 112-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NICHD NIH HHS, U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
Abstract (Originalsprache)
Most people with intellectual disability (ID) do not receive a molecular diagnosis following genetic testing. To identify new etiologies of ID, we performed a genetic association analysis comparing the burden of rare variants in 41,132 noncoding genes between 5,529 unrelated cases and 46,401 unrelated controls. RNU4-2 , which encodes U4 small nuclear RNA, a critical component of the spliceosome, was the most strongly associated gene. We implicated de novo variants among 47 cases in two regions of RNU4-2 in the etiology of a syndrome characterized by ID, microcephaly, short stature, hypotonia, seizures and motor delay. We replicated this finding in three collections, bringing the number of unrelated cases to 73. Analysis of national genomic diagnostic data showed RNU4-2 to be a more common etiological gene for neurodevelopmental abnormality than any previously reported autosomal gene. Our findings add to the growing evidence of spliceosome dysfunction in the etiologies of neurological disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Cambridge, Cambridge, UK.
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Department of Cardiovascular Sciences, Center for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium.
- NHS South West Genomic Laboratory Hub, Southmead Hospital, Bristol, UK.
- NHS South West Genomic Medicine Service Alliance, Bristol, UK.
- Clinical Genetics Unit, Birmingham Women's Hospital, Birmingham, UK.
ORCID-Profile: Els Ortibus, Kathleen Freson, Ernest Turro
Förderung
- NHLBI NIH HHS
- NICHD NIH HHS
- U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)
Zitieren
APA
Greene, D., Thys, C., Berry, I. R., Jarvis, J., Ortibus, E., Mumford, A. D., Freson, K., & Turro, E. (2024). Mutations in the U4 snRNA gene RNU4-2 cause one of the most prevalent monogenic neurodevelopmental disorders. Nature Medicine, 30(8), 2165-2169. https://doi.org/10.1038/s41591-024-03085-5
Vancouver
Greene D, Thys C, Berry IR, Jarvis J, Ortibus E, Mumford AD, et al. Mutations in the U4 snRNA gene RNU4-2 cause one of the most prevalent monogenic neurodevelopmental disorders. Nature Medicine. 2024;30(8):2165-2169. doi:10.1038/s41591-024-03085-5
BibTeX
@article{Greene2024,
author = {Greene, Daniel and Thys, Chantal and Berry, Ian R and Jarvis, Joanna and Ortibus, Els and Mumford, Andrew D and Freson, Kathleen and Turro, Ernest},
title = {Mutations in the U4 snRNA gene RNU4-2 cause one of the most prevalent monogenic neurodevelopmental disorders},
journal = {Nature Medicine},
year = {2024},
volume = {30},
number = {8},
pages = {2165--2169},
doi = {10.1038/s41591-024-03085-5}
}
EUVIMED